This inventor holds 1 USPTO granted patent. Top assignee: National Taiwan University. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Yen-Ching Chen: Innovator in Esophageal Cancer Treatment
Introduction
Yen-Ching Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment, particularly in understanding the genetic markers associated with esophageal cancer.
Latest Patents
Yen-Ching Chen holds a patent titled "Biomarkers for predicting response of esophageal cancer patient to chemoradiotherapy." This invention relates to novel genetic markers that are associated with the response of patients with esophageal cancer to chemoradiation therapy. The patent outlines methods and kits for predicting a patient's response to treatment through the genotyping of these markers. He has 1 patent to his name.
Career Highlights
Chen is affiliated with National Taiwan University, where he conducts research and develops innovative solutions for cancer treatment. His work has the potential to improve patient outcomes by providing personalized treatment options based on genetic information.
Collaborations
Yen-Ching Chen collaborates with esteemed colleagues, including Eric Chuang and Pei-Chun Chen, who contribute to his research efforts in the field of oncology.
Conclusion
Yen-Ching Chen's work in identifying genetic markers for esophageal cancer treatment represents a significant advancement in personalized medicine. His contributions are paving the way for more effective treatment strategies for patients facing this challenging disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile